Clinical Trial Update: Impact of Obstructive SAS on Metastatic Potential of Cutaneous Melanoma [EARLY_Phase 1]

View source ↗

Summary

A phase 1 trial evaluating the impact of obstructive sleep apnea on metastatic potential in cutaneous melanoma has been withdrawn. The study involved melanoma w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: AGIR à Dom | Conditions: Melanoma With a Breslow's Thickness ≥ 1mm, Obstructive Sleep Apnea Syndrome | EARLY_Phase 1 | Status: WITHDRAWN